Cas:78706-11-3 2-(5-Methyl-2-furyl)-1H-benzimidazole manufacturer & supplier

We serve Chemical Name:2-(5-Methyl-2-furyl)-1H-benzimidazole CAS:78706-11-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(5-Methyl-2-furyl)-1H-benzimidazole

Chemical Name:2-(5-Methyl-2-furyl)-1H-benzimidazole
CAS.NO:78706-11-3
Synonyms:2-(5-Methyl-2-furyl)-1H-benzimidazole
Molecular Formula:C12H10N2O
Molecular Weight:198.22100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.82000
Exact Mass:198.07900
LogP:3.13130

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(5-Methyl-2-furyl)-1H-benzimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(5-Methyl-2-furyl)-1H-benzimidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(5-Methyl-2-furyl)-1H-benzimidazole Use and application,2-(5-Methyl-2-furyl)-1H-benzimidazole technical grade,usp/ep/jp grade.


Related News: Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 2-(5-Methyl-2-furyl)-1H-benzimidazole manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 2-(5-Methyl-2-furyl)-1H-benzimidazole supplier Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 2-(5-Methyl-2-furyl)-1H-benzimidazole vendor Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 2-(5-Methyl-2-furyl)-1H-benzimidazole factory The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island.